Muscular dystrophy associated with α-dystroglycan deficiency in Sphynx and Devon Rex cats

Neuromuscular Disorders

Volumn 18, Issue 12, 2008, Pages 942-952

  Martin, Paul T ^a   Shelton, G Diane ^b   Dickinson, Peter J ^c   Sturges, Beverly K ^c   Xu, Rui ^a   LeCouteur, Richard A ^c   Guo, Ling T ^b   Grahn, Robert A ^d   Lo, Harriet P ^e   North, Kathryn N ^e   Malik, Richard ^f   Engvall, Eva ^g   Lyons, Leslie A ^d  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g BURNHAM INSTITUTE   (United States)

Author keywords

Devon Rex; Dystroglycan; Feline; Glycosylation; Muscular Dystrophy; Neuromuscular; Sphynx

Indexed keywords

ALPHA DYSTROGLYCAN; BETA DYSTROGLYCAN; DYSTROPHIN; LAMININ; LAMININ ALPHA2; LAMININ BINDING PROTEIN; MESSENGER RNA; SARCOGLYCAN;

ALPHA DYSTROGLYCAN DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FELINE DYSTROGLYCAN GENE; FEMALE; GENE; GENE MUTATION; GLYCOSYLATION; HISTOLOGY; IMMUNOBLOTTING; LECTIN BINDING; LIGAND BINDING; MALE; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SKELETAL MUSCLE;

ANIMALS; BIOPSY; CATS; DISEASE MODELS, ANIMAL; DYSTROGLYCANS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSYLATION; IMMUNOBLOTTING; LAMININ; LECTINS; MALE; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; POLYMERASE CHAIN REACTION;

EID: 56949093730     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.08.002     Document Type: Article

References (76)

1. Hoffman E.P., Brown Jr. R.H., and Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51 (1987) 919-928
2. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., and Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50 (1987) 509-517
3. Jimenez-Mallebrera C., Brown S.C., Sewry C.A., and Muntoni F. Congenital muscular dystrophy: molecular and cellular aspects. Cell Mol Life Sci 62 (2005) 809-823
4. Emery A.E. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord 1 (1991) 19-29
5. Martin P.T. Mechanisms of Disease: congenital muscular dystrophies-glycosylation takes center stage. Nat Clin Pract Neurol 2 (2006) 222-230
6. Cooper B.J., Winand N.J., Stedman H., et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy in dogs. Nature 334 (1988) 154-156
7. Sharp N.J., Kornegay J.N., Van Camp S.D., et al. An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13 (1992) 115-121
8. Howell J.M., Fletcher S., Kakulas B.A., O'Hara M., Lochmuller H., and Karpati G. Use of the dog model for Duchenne muscular dystrophy in gene therapy trials. Neuromuscul Disord 7 (1997) 325-328
9. Gashen F.P., Hoffman E.P., Gorospe J.R., Uhl E.W., Senior D.F., Cardinet III G.H., et al. Dystrophin deficiency causes lethal muscle hypertrophy in cats. J Neurol Sci 110 (1992) 149-159
10. O'Brien D.P., Johnson G.C., Liu L.A., Guo L.T., Engvall E., Powell H.C., et al. Laminin 2 (merosin)-deficient muscular dystrophy and demyelinating neuropathy in two cats. J Neurol Sci 189 (2001) 37-43
11. Sicinski P., Geng Y., Ryder-Cook A.S., Barnard E.A., Darlison M.G., and Barnard P.J. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244 (1989) 1578-1580
12. Xu H., Christmas P., Wu X.R., Wewer U.M., and Engvall E. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci USA 91 (1994) 5572-5576
13. Durbeej M., and Campbell K.P. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev (2002) 349-361
14. Sakamoto A., Ono K., Abe M., Jasmin G., Eki T., Murakami Y., et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 94 (1997) 13873-13878
15. Saito F., Blank M., Schroder J., et al. Aberrant glycosylation of α-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy. FEBS Lett 579 (2005) 2359-2363
16. Mendell J.R., Boue D.R., and Martin P.T. The congenital muscular dystrophies: recent advances and molecular insights. Pediatr Dev Pathol 9 (2006) 427-443
17. Barresi R., and Campbell K.P. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 119 (2006) 199-207
18. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., and Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355 (1992) 696-702
19. Ervasti J.M., and Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122 (1993) 809-823
20. Henry M.D., and Campbell K.P. Dystroglycan inside and out. Curr Opin Cell Biol 11 (1999) 602-607
21. Cohn R.D., Henry M.D., Michele D.E., et al. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 110 (2002) 639-648
22. Russo K., Di Stasio E., Macchia G., Rosa G., Brancassio A., and Petrucci T.C. Characterization of the β-dystroglycan-growth factor receptor 2 (Grb2) interaction. Biochem Biophys Res Commun 274 (2000) 93-98
23. Chockalingam P.S., Cholera R., Oak S.A., Zheng Y., Jarrett H.W., and Thomason D.B. Dystrophin-glycoprotein complex and Ras and Rho GTPase signaling are altered in muscle atrophy. Am J Physiol Cell Physiol 283 (2002) C500-C511
24. Langenback K.J., and Rando T.A. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells. Muscle Nerve 26 (2002) 644-653
25. Spence H.J., Dhillon A.S., James M., and Winder S.J. Dystroglycan, a scaffold for the ERK-MAP kinase cascade. EMBO Rep 5 (2004) 484-489
26. Zhou Y.W., Thomnason D.B., Gullberg D., and Jarrett H.W. Binding of laminin alpha 1-chain LG4-5 domain to α-dystroglycan causes tyrosine phosphorylation of syntrophin to initiate Rac1 signaling. Biochemistry 45 (2006) 2042-2052
27. Beltran-Valero de Bernabe D., Currier S., Steinbrecher A., et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 71 (2002) 1033-1043
28. van Reeuwijk J., Janssen M., van den Elzen C., et al. POMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet 42 (2005) 907-912
29. Kobayashi K., Nakahori Y., Miyake M., et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394 (1998) 388-392
30. Beltran-Valero de Bernabe D., Voit T., Longman C., et al. Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J Med Genet 41 (2004) e61
31. Longman C., Brockington M., Torelli S., et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of α-dystroglycan. Hum Mol Genet 12 (2003) 2853-2861
32. Manya H., Sakai K., Kobayashi K., Taniguchi K., Kawakita M., Toda T., et al. Loss-of-function of an N-acetylglucosaminyltransferase, POMNGnT1, in muscle-eye-brain disease. Biochem Biophys Res Commun 306 (2003) 93-97
33. Brockington M., Blake D.J., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha 2 deficiency and abnormal glycosylation of α-dystroglycan. Am J Hum Genet 69 (2001) 1198-1209
34. Brockington M., Yuva Y., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 10 (2001) 2851-2859
35. Godfrey C., Clement E., Mein R., et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 130 Pt 10 (2007) 2725-2735
36. Hayashi Y.K., Ogawa M., Tagawa K., Noguchi S., Ishihara T., Nonaka I., et al. Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57 (2001) 115-121
37. Kano H., Kobayashi K., Herrmann R., et al. Deficiency of α-dystroglycan in muscle-eye-brain disease. Biochem Biophys Res Commun 291 (2002) 1283-1286
38. Topaloglu H., Brockington M., Yuva Y., et al. FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts. Neurology 60 (2003) 988-992
39. Michele D.E., Barresi R., Kanagawa M., et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418 (2002) 417-422
40. Malik R., Mepstead K., Yang F., and Harper C. Hereditary myopathy of Devon Rex cats. J Small Anim Pract 34 (1993) 539-546
41. Robinson R. 'Spasticity' in the Devon Rex cat. Vet Rec 130 (1992) 302
42. Dickinson P.J., Anderson P.J., Williams D.C., Powell H.C., Shelton G.D., Morris J.G., et al. Assessment of the neurologic effects of dietary deficiencies of phenylalanine and tyrosine in cats. Am J Vet Res 65 (2004) 671-680
43. Redding R.W., and Ingram J.T. Sensory nerve conduction velocity of cutaneous afferents of the radial, ulnar, peroneal, and tibial nerves of the cat: reference values. Am J Vet Res 45 (1984) 1042-1045
44. Redding R.W., Lee A.H., and Wilson S.G. Spinal-evoked potentials and spinal conduction velocity of the cat: reference values. Am J Vet Res 45 (1984) 2175-2177
45. Malik R., and Ho S. Motor-nerve conduction parameters in the cat. J Small Anim Pract 30 (1989) 396-400
46. Leivo I., and Engvall E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci USA 85 (1988) 1544-1548
47. Liu L.A., and Engvall E. Sarcoglycan isoforms in skeletal muscle. J Biol Chen 274 (1999) 38171-38176
48. Xia B., Hoyte K., Kammesheidt A., Deerinck T., Ellisman M., and Martin P.T. Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression. Dev Biol 242 (2002) 58-73
49. Hoyte K., Jayasinha V., Xia B., and Martin P.T. Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice. Am J Pathol 164 (2004) 711-718
50. Nguyen H.H., Jayasinha V., Xia B., Hoyte K., and Martin P.T. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice. Proc Natl Acad Sci USA 99 (2002) 5616-5621
51. Cooper S.T., Lo H.P., and North K.N. Single section Western blot: improving the molecular diagnosis of the muscular dystrophies. Neurology 61 (2003) 93-97
52. Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. Basic local alignment search tool. J Mol Biol 215 (1990) 403-410
53. Dickinson P.J., Roberts B.N., Higgins R.J., Leutenegger C.M., Bollen A.W., Kass P.H., et al. Expression of receptor tyrosine kinases VEGFR-1 (FLT-1), VEGFR-2 (KDR), EGFR-1, PDGFRα and c-Met in canine primary brain tumors. Veterinary and Comparative Oncology 4 (2006) 132-140
54. Hirst R.C., McCullagh K.J., and Davies K.E. Utrophin upregulation in Duchenne muscular dystrophy. Acta Myol 24 (2005) 209-216
55. Gramolini A.O., Karpati G., and Jasmin B.J. Discordant expression of utrophin and its transcript in human and mouse skeletal muscles. J Neuropathol Exp Neurol 58 (1999) 235-244
56. Matsumura K., Ervasti J.M., Ohlendieck K., Kahl S.D., and Campbell K.P. Association of dystrophin-related protein with dystrophin-associated protein in mdx mouse muscle. Nature 360 (1992) 588-591
57. Ervasti J.M., Roberds S.L., Anderson R.D., Sharp N.J., Kornegay J.N., and Campbell K.P. α-dystroglycan deficiency correlates with elevated serum creatine kinase and decreased muscle contraction tension in golden retriever muscular dystrophy. FEBS Lett 350 (1994) 173-176
58. D'Amico A., Tessa A., Bruno C., et al. Expanding the clinical spectrum of POMT1 phenotype. Neurology 66 (2006) 1564-1567
59. Balci B., Uyanik G., Dincer P., et al. An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene. Neuromuscul Disord 15 (2005) 271-275
60. Brown S.C., Torelli S., Brockington M., et al. Abnormalities in α-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies. Am J Pathol 164 (2004) 727-737
61. Jacobson C., Montanaro F., Lindenbaum M., Carbonetto S., and Ferns M. α-dystroglycan functions in acetylcholine receptor aggregation but is not a co-receptor for agrin-MuSK signaling. J Neurosci 18 (1998) 6340-6348
62. Saito F., Masaki T., Saito Y., et al. Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice. J Neurochem 101 (2007) 1712-1722
63. Cote P.D., Moukhles H., Lindenbaum M., and Carbonetto S. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat Genet 23 (1999) 338-342
64. Taniguchi M., Kurahashi H., Noguchi S., et al. Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in α-dystroglycanopathies. Hum Mol Genet 15 (2006) 1279-1289
65. McNally E.M. New approaches in the therapy of cardiomyopathy in muscular dystrophy. Ann Rev Med 58 (2007) 75-88
66. Valentine B.A., Cummings J.F., and Cooper B.J. Development of Duchenne-type cardiomyopathy. Morphologic studies in a canine model. Am J Pathol 135 (1989) 671-678
67. Nigro V., Okazaki Y., Belsito A., et al. Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet 6 (1997) 601-607
68. Nakanishi T., Sakauchi M., Kaneda Y., Tomimatsu H., Saito K., Nakazawa M., et al. Cardiac involvement in Fukuyama-type congenital muscular dystrophy. Pediatrics 117 (2006) e1187-e1192
69. Poppe M., Bourke J., Eagle M., et al. Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol 56 (2004) 738-741
70. Cat Fanciers'Association. Cat Fanciers' Association Registration Totals by Color and Breed-2003, and 1/1/58 to 12/31/03. Cat Fanciers' Almanac 2004;20:72-86.
71. Letard E. Hairless siamese cats. J Hered 64 (1938) 47-49
72. Robinson R. The Canadian hairless or sphinx cat. J Hered 64 (1973) 47-49
73. Robinson R. A third hypotrichosis in the domestic cat. Genetica 55 (1981) 39-40
74. Hendy-Ibbs P.M. Hairless cats in great Britain. J Hered 75 (1984) 506-507
75. Lipinski MJ, Froenicke L, Baysac KC, Billings NC, Leutenegger CM, Levy AM, et al. The ascent of cat breeds: genetic evaluations of breeds and worldwide random-bred populations. Genomics 2007;Nov 28:[Epub ahead of print].
76. Menotti-Raymond M, David VA, Pflueger SM, Lindblad-Toh K, Wade CM, O'Brien SJ, et al. Patterns of molecular genetic variation among cat breeds. Genomics 2007;Oct 24: [Epub ahead of print].